Bleasdale J E, Thakur N R, Rader G R, Tesan M
Biochem J. 1985 Dec 1;232(2):539-45. doi: 10.1042/bj2320539.
Results of previous investigations support the proposition that, in type II pneumonocytes, CMP is involved in integration of the synthesis of phosphatidylcholine and phosphatidylglycerol for lung surfactant. In the present investigation, the amount of CMP in rat type II pneumonocytes was altered directly and resultant changes in the synthesis of phosphatidylglycerol were examined. Type II pneumonocytes were made permeable to CMP by treatment with Ca2+-free medium, and phosphatidylglycerol synthesis was then assessed by measurement of the incorporation of a radiolabelled precursor, [14C]glycerol 3-phosphate, that was not effectively utilized by cells that resisted permeabilization. Incorporation of [14C]glycerol 3-phosphate into phosphatidylglycerol (but not into other lipids) was stimulated greatly by CMP (half-maximal stimulation at approx. 0.1 mM). CMP stimulated the incorporation of [14C]glycerol 3-phosphate into both the phosphatidyl moiety and the head group of phosphatidylglycerol. Incorporation of [14C]palmitate into phosphatidylglycerol was also stimulated by CMP. myo-Inositol, at concentrations found in foetal-rat serum (0.2-2.0 mM), inhibited CMP-dependent incorporation of [14C]glycerol 3-phosphate into phosphatidylglycerol and promoted, instead, CMP-dependent incorporation into phosphatidylinositol. These data, when extrapolated to foetal type II pneumonocytes, are consistent with the view that the developmental increase in the synthesis of phosphatidylglycerol for surfactant by foetal lungs is promoted by the increase in intracellular CMP and the declining availability of myo-inositol that were found previously to be associated with this period of development.
先前的研究结果支持这样一种观点,即在II型肺细胞中,CMP参与肺表面活性剂中磷脂酰胆碱和磷脂酰甘油合成的整合。在本研究中,直接改变大鼠II型肺细胞中CMP的量,并检测由此导致的磷脂酰甘油合成的变化。通过用无Ca2+培养基处理使II型肺细胞对CMP通透,然后通过测量放射性标记前体[14C]甘油3-磷酸的掺入来评估磷脂酰甘油的合成,该前体不能被抗通透化的细胞有效利用。CMP极大地刺激了[14C]甘油3-磷酸掺入磷脂酰甘油(但不掺入其他脂质)(在约0.1 mM时达到半最大刺激)。CMP刺激[14C]甘油3-磷酸掺入磷脂酰甘油的磷脂部分和头部基团。CMP也刺激[14C]棕榈酸酯掺入磷脂酰甘油。在胎鼠血清中发现的浓度(0.2 - 2.0 mM)的肌醇抑制CMP依赖性的[14C]甘油3-磷酸掺入磷脂酰甘油,反而促进CMP依赖性的掺入磷脂酰肌醇。当将这些数据外推到胎儿II型肺细胞时,与以下观点一致,即胎儿肺表面活性剂磷脂酰甘油合成的发育性增加是由细胞内CMP的增加和先前发现与这一发育时期相关的肌醇可用性下降所促进的。